Chemring Group PLC — Director's Dealing 2019

Oct 14, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8299P

Chemring Group PLC

14 October 2019

14 October 2019

Chemring Group PLC

PDMR share dealing

Chemring Group PLC ("Chemring" or "the Company") announces that it has been notified that Laurie Bowen, a director of the Company, on 11 October 2019 bought 15,000 1p ordinary shares in the capital of the Company at an average price of $2.51 (equivalent to 198p) per share.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Laurie Bowen

2

Reason for the notification

a)

Position/status

Director/PDMR

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Chemring Group PLC

b)

LEI

213800U9A54VQJ5P2J41

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

1p ordinary shares

GB00B45C9X44

b)

Nature of the transaction

Purchase of 1p ordinary shares

c)

Price(s) and volume(s)

Price(s)	Volume(s)
198p	15,000

d)

Aggregated information

- Aggregated volume

- Price

15,000 1p ordinary shares

198p per share

e)

Date of the transaction

11 October 2019

f)

Place of the transaction

UK

For further information:

Chemring Group PLC
Sarah Ellard	Group Legal Director	+44 (0)1794 833 901

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLLFVEILLSLIA